Logo

XRAY

DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc. • NASDAQ
$11.34 ▲ 0.44% (+0.05)
Market Cap $2.26 B
52w High $20.60
52w Low $9.85
Dividend Yield 0.64%
P/E -2.58
Volume 2.30M
Outstanding Shares 199.55M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $904M ▼ $392M ▼ $-427M ▼ -47.235% ▼ $-2.14 ▼ $-114M ▼
Q2-2025 $936M ▲ $618M ▲ $-45M ▼ -4.808% ▼ $-0.23 ▼ $-41M ▼
Q1-2025 $879M ▼ $403M ▼ $20M ▲ 2.275% ▲ $0.1 ▲ $142M ▲
Q4-2024 $905M ▼ $955M ▼ $-430M ▲ -47.514% ▲ $-2.16 ▲ $-419M ▼
Q3-2024 $951M $957M $-494M -51.945% $-2.46 $-371M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $363M ▲ $5.653B ▼ $4.175B ▲ $1.478B ▼
Q2-2025 $359M ▼ $6.069B ▲ $4.108B ▲ $1.96B ▼
Q1-2025 $398M ▲ $6.05B ▲ $4.04B ▲ $2.01B ▲
Q4-2024 $272M ▼ $5.753B ▼ $3.81B ▼ $1.942B ▼
Q3-2024 $296M $6.626B $4.136B $2.491B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-427M ▼ $79M ▲ $-36M ▼ $-36M ▲ $4M ▲ $40M ▲
Q2-2025 $-45M ▼ $48M ▲ $-34M ▼ $-68M ▼ $-39M ▼ $16M ▲
Q1-2025 $19M ▲ $7M ▼ $-17M ▲ $123M ▲ $126M ▲ $-12M ▼
Q4-2024 $-428M ▲ $87M ▼ $-57M ▼ $-38M ▲ $-24M ▼ $36M ▼
Q3-2024 $-495M $141M $-47M $-79M $17M $98M

Revenue by Products

Product Q2-2022Q3-2022Q4-2022Q1-2023
Consumables Segment
Consumables Segment
 $430.00M ▲$390.00M ▼$380.00M ▼$430.00M ▲
Technologies And Equipment
Technologies And Equipment
 $590.00M ▲$560.00M ▼$600.00M ▲$550.00M ▼

Five-Year Company Overview

Income Statement

Income Statement Revenue has been fairly stable in recent years, but profits have been weak and uneven. The company has only managed a solid profit in one of the past five years, with sizable losses recently, suggesting meaningful restructuring charges, write‑downs, or margin pressure. Gross profitability on products still looks healthy, but operating costs and other charges are eating up that value. Overall, the income statement points to a business that sells a lot, but has struggled to convert those sales into consistent earnings, especially over the last two years.

Balance Sheet

Balance Sheet The balance sheet shows a company that has become lighter in total assets and equity over time, while debt has stayed roughly the same. That means leverage has increased and the financial cushion from shareholder equity has shrunk. Cash on hand looks modest relative to the size of the business, so balance sheet flexibility is not especially strong. The picture is of a company that still has substantial scale but with less room for error than a few years ago, making execution on its turnaround particularly important.

Cash Flow

Cash Flow Despite accounting losses, the business continues to generate positive cash from operations and positive free cash flow. Cash generation has trended down from earlier years but remains solid enough to support ongoing investment in equipment and technology, given its relatively modest capital spending needs. In simple terms, cash flow quality is better than the recent earnings suggest, but there is less surplus than before, which may limit how aggressively the company can invest or reduce debt without trade‑offs.

Competitive Edge

Competitive Edge Dentsply Sirona holds a strong position in dental equipment and consumables, with a well‑known brand, a broad product range, and deep relationships with dentists and labs worldwide. Its main edge is an integrated digital workflow—scanners, software, milling, imaging, and services—that can make it hard for existing customers to switch away. However, the dental market is crowded and price‑competitive. In key growth areas like implants and clear aligners, focused rivals have been growing faster and are often seen as technically ahead. Overall, the company has meaningful strengths and switching‑cost advantages, but its moat is contested and not clearly dominant in several of the fastest‑growing niches.

Innovation and R&D

Innovation and R&D The company has a long history of shaping digital dentistry, from CEREC chairside systems to cloud‑based DS Core, advanced scanners, and 3D‑printed dentures. Its strategy now centers on tightening this digital ecosystem, using software, cloud connectivity, and eventually more AI to lock in users and streamline clinical workflows. A pipeline of new products and a renewed push in areas like endodontics, implants, and clear aligners show a strong commitment to R&D. The opportunity is to turn this innovation engine into higher growth and better margins; the risk is execution—ensuring new platforms gain adoption quickly enough in markets where competitors are moving just as fast.

Summary

Dentsply Sirona today looks like a technologically advanced dental leader working through a difficult financial and strategic transition. Sales are relatively steady, cash flows are positive, and its digital ecosystem remains a key asset. At the same time, profitability has been inconsistent, the balance sheet is more leveraged than before, and competitors are pressing hard in the most attractive segments. The investment case around the company’s future hinges on whether management can translate its strong innovation pipeline and integrated platform into sustained growth, margin improvement, and a stronger financial profile over the next few years.

NEWS

November 6, 2025 · 8:00 AM UTC

Dentsply Sirona Reports Third Quarter 2025 Results

Read more

October 24, 2025 · 10:40 AM UTC

Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights

Read more

October 8, 2025 · 4:15 PM UTC

Dentsply Sirona to Host Third Quarter Conference Call on November 6th

Read more

October 2, 2025 · 8:30 AM UTC

Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization

Read more

September 25, 2025 · 10:56 AM UTC

Dentsply Sirona and Pearl Partner to Deliver Advanced AI-Assisted Radiologic Support via DS Core Integration

Read more